Formulation d'anticorps il-17
La présente invention concerne des formulations pharmaceutiques stabilisées pour anticorps anti-il -17, comprenant par exemple du citrate, du chlorure de sodium et du polysorbate -80 à un ph de 5,7. Ces formulations pharmaceutiques stabilisées pour anticorps anti-il -17 peuvent être utilisées pour t...
Saved in:
| Main Authors | , , , |
|---|---|
| Format | Patent |
| Language | French |
| Published |
31.10.2016
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | La présente invention concerne des formulations pharmaceutiques stabilisées pour anticorps anti-il -17, comprenant par exemple du citrate, du chlorure de sodium et du polysorbate -80 à un ph de 5,7. Ces formulations pharmaceutiques stabilisées pour anticorps anti-il -17 peuvent être utilisées pour traiter l'arthrite rhumatoïde, le psoriasis, la spondylite ankylosante, l'arthrite psoriasique ou le myélome multiple.
The present invention provides pharmaceutical formulations for anti-IL-17 antibodies. These anti-IL-17 antibody pharmaceutical formulations can be used to treat rheumatoid arthritis, psoriasis, ankylosing spondilitis, psoriatic arthritis or multiple myeloma. |
|---|---|
| AbstractList | La présente invention concerne des formulations pharmaceutiques stabilisées pour anticorps anti-il -17, comprenant par exemple du citrate, du chlorure de sodium et du polysorbate -80 à un ph de 5,7. Ces formulations pharmaceutiques stabilisées pour anticorps anti-il -17 peuvent être utilisées pour traiter l'arthrite rhumatoïde, le psoriasis, la spondylite ankylosante, l'arthrite psoriasique ou le myélome multiple.
The present invention provides pharmaceutical formulations for anti-IL-17 antibodies. These anti-IL-17 antibody pharmaceutical formulations can be used to treat rheumatoid arthritis, psoriasis, ankylosing spondilitis, psoriatic arthritis or multiple myeloma. |
| Author | WILLIAMS, Barbara, Ann DONOVAN, Patrick, Daniel MARKHAM, Aaron, Paul CORVARI, Vincent, John |
| Author_xml | – fullname: DONOVAN, Patrick, Daniel – fullname: MARKHAM, Aaron, Paul – fullname: WILLIAMS, Barbara, Ann – fullname: CORVARI, Vincent, John |
| BookMark | eNrjYmDJy89L5WSQdcsvyi3NSSzJzM9TSFFPzCvJTM4vKihWyMzRNTTnYWBNS8wpTuWF0twMcm6uIc4euqkF-fGpxQWJyal5qSXxvo7G5saG5k6GxgQVAACiOSQc |
| ContentType | Patent |
| DBID | EVB |
| DatabaseName | esp@cenet |
| DatabaseTitleList | |
| Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Chemistry Sciences |
| ExternalDocumentID | MA37317B1 |
| GroupedDBID | EVB |
| ID | FETCH-epo_espacenet_MA37317B13 |
| IEDL.DBID | EVB |
| IngestDate | Fri Jul 19 14:54:52 EDT 2024 |
| IsOpenAccess | true |
| IsPeerReviewed | false |
| IsScholarly | false |
| Language | French |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-epo_espacenet_MA37317B13 |
| Notes | Application Number: MA20140037317 |
| OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20161031&DB=EPODOC&CC=MA&NR=37317B1 |
| ParticipantIDs | epo_espacenet_MA37317B1 |
| PublicationCentury | 2000 |
| PublicationDate | 20161031 |
| PublicationDateYYYYMMDD | 2016-10-31 |
| PublicationDate_xml | – month: 10 year: 2016 text: 20161031 day: 31 |
| PublicationDecade | 2010 |
| PublicationYear | 2016 |
| RelatedCompanies | ELI LILLY AND COMPANY |
| RelatedCompanies_xml | – name: ELI LILLY AND COMPANY |
| Score | 2.922721 |
| Snippet | La présente invention concerne des formulations pharmaceutiques stabilisées pour anticorps anti-il -17, comprenant par exemple du citrate, du chlorure de... |
| SourceID | epo |
| SourceType | Open Access Repository |
| SubjectTerms | CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
| Title | Formulation d'anticorps il-17 |
| URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20161031&DB=EPODOC&locale=&CC=MA&NR=37317B1 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV3dS8MwED_GFPVN57du9EHqU9A2XRsfitgvhtBtyJS9jSZZZCBa2or_vteYqS97Cwlckkvu7nf5uAO44q5iVLicUMZ84nEVkLtCCKKGDpcSEbKr07flY3_07D3Oh_MOvK7_wug4oV86OCJKlEB5b7S-Lv8OsRL9trK-4Sus-rjPZmFiG-8Y4QtuUjuJwnQ6SSaxHcchqq7xU0gDNJQRuklbLYZug-ynL1H7JaX8b0-yfdieIqn35gA6qurBbrxOu9aDndzcdmPRCF59CP0MsaXJtGXJa2QHrmBV1tbqjTjBEQyydBaPCPaz-J3RIn8w46HH0EU3f3kKln8rhFJOIZlCK1v4HLERQ3xDGVdSeMUZnGwgcr6x5QL2Wqb86NpL6DbV57KPRrThA82Ab7EwdnY |
| link.rule.ids | 230,309,786,891,25594,76903 |
| linkProvider | European Patent Office |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV1LT4NAEJ401djetL61lYPB00Z5FNYDMQIlqIU2Bk1vhF26pompBDD-facrVS-9bXaTfczuzHzfvgbgkumCGlxnxKDUIiYTNrnNOCdiqLE8R4Ssy_BtUWyFL-bjbDhrwdv6LYz8J_RLfo6IGsVR32tpr4u_TSxf3q2srtkCsz7ugsTx1YYdI3zBRar6rjOaTvyJp3qeg6YrfnYMGx2lizRpy0Y-KHnSq7t6klL89yfBLmxPsaplvQctUfag463DrvVgJ2pOuzHZKF61D_0AsWUTaUvJr1AcOINlUSmLd6LZBzAIRokXEmwn_R1RGt03_TEOoY00f34MinXDuRBallOBXjazGGIjivjGoEzk3MxO4GhDJacbSy6gEybROB0_xE9n0F0J6MfunkO7Lj_nfXSoNRtIYXwDYAZ5YA |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Formulation+d%27anticorps+il-17&rft.inventor=DONOVAN%2C+Patrick%2C+Daniel&rft.inventor=MARKHAM%2C+Aaron%2C+Paul&rft.inventor=WILLIAMS%2C+Barbara%2C+Ann&rft.inventor=CORVARI%2C+Vincent%2C+John&rft.date=2016-10-31&rft.externalDBID=B1&rft.externalDocID=MA37317B1 |